His scientific interests lie mostly in Pathology, Cerebrospinal fluid, Internal medicine, Central nervous system disease and Glial fibrillary acidic protein. Lars Rosengren has included themes like Multiple sclerosis, Cerebral infarction and Central nervous system in his Pathology study. His research integrates issues of Alzheimer's disease, Tau protein, Stroke and Dementia, Vascular dementia in his study of Cerebrospinal fluid.
Lars Rosengren combines subjects such as Vascular disease and Cytokine with his study of Stroke. His Internal medicine research includes elements of Gastroenterology, Glasgow Coma Scale, Endocrinology and Cardiology. His biological study spans a wide range of topics, including Neurology and Astrogliosis.
His primary areas of study are Cerebrospinal fluid, Pathology, Internal medicine, Glial fibrillary acidic protein and Endocrinology. His Cerebrospinal fluid study incorporates themes from Neurofilament, Central nervous system disease, Immunology, Dementia and Brain damage. His Pathology research is multidisciplinary, relying on both Multiple sclerosis and Central nervous system.
His work deals with themes such as Gastroenterology, Anesthesia and Glasgow Outcome Scale, which intersect with Internal medicine. His research in Glial fibrillary acidic protein intersects with topics in Enolase, Gliosis, Astrogliosis and Neurofilament light. His study explores the link between Endocrinology and topics such as Gerbil that cross with problems in Cerebellar vermis.
Lars Rosengren spends much of his time researching Cerebrospinal fluid, Internal medicine, Pathology, Stroke and Biomarker. His Cerebrospinal fluid research includes themes of Progressive supranuclear palsy, Atrophy, Neurofilament, Tau protein and Parkinson's disease. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Depression and Immunology.
The concepts of his Pathology study are interwoven with issues in Multiple sclerosis and Central nervous system disease. His work focuses on many connections between Central nervous system disease and other disciplines, such as Head injury, that overlap with his field of interest in Traumatic brain injury. His Stroke research incorporates elements of Neurology and Risk factor.
Lars Rosengren mainly investigates Cerebrospinal fluid, Pathology, Glial fibrillary acidic protein, Multiple sclerosis and Anesthesia. His Cerebrospinal fluid study is concerned with the larger field of Internal medicine. His Pathology study integrates concerns from other disciplines, such as White matter and Hyperintensity.
His research in Glial fibrillary acidic protein intersects with topics in Case-control study, Parkinson's disease, Differential diagnosis, Corticobasal degeneration and Intensive care unit. His Multiple sclerosis study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke
Elisabeth Tarkowski;Lars Rosengren;Christian Blomstrand;Carsten Wikkelsö.
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.
Camilla Hesse;Lars Rosengren;Niels Andreasen;Pia Davidsson.
Neuroscience Letters (2001)
Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology
Annika Olsson;Hugo Vanderstichele;Niels Andreasen;Geert De Meyer.
Clinical Chemistry (2005)
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.
Lars E. Rosengren;Jan-Erik Karlsson;Jan-Olof Karlsson;Lennart I. Persson.
Journal of Neurochemistry (2002)
Neurochemical Aftermath of Amateur Boxing
Henrik Zetterberg;M. Albert Hietala;Michael Jonsson;Niels Andreasen.
JAMA Neurology (2006)
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
Martin Gunnarsson;Clas Malmeström;Markus Axelsson;Peter Sundström.
Annals of Neurology (2011)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C. Malmeström;S. Haghighi;L. Rosengren;O. Andersen.
Elevated Neurofilament Levels in Neurological Diseases
Niklas Norgren;Lars Rosengren;Torgny Stigbrand.
Brain Research (2003)
General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke).
Pia Löwhagen Hendén;Alexandros Rentzos;Jan-Erik Karlsson;Lars Rosengren.
Cerebrovascular Complications in Patients with Left-Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers
Ulrika Snygg-Martin;Lars E Gustafsson;Lars Rosengren;Åsa Alsiö.
Clinical Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: